Pharmaceuticals, Biotechnology & Life Sciences

Insider selling signals? Stephen Bloch’s July 1 Liquidia shares sale shows confidence amid bullish momentum—what investors should watch.

Valetudo’s 4.37 M share transfer to Ewon boosts voting power, potentially reshaping LIMINATUS strategy and stock outlook.

Insider buying by Lawrence Leibowitz and peers shows a bullish outlook for Hyperliquid, boosting confidence in its crypto‑derivatives growth strategy.

Insightful review of Liu Joy’s July 1 insider sale at Vertex Pharma—why it’s a routine plan, not a warning, and what it means for bullish investors.

CEO William Morachnick’s July 2026 share purchases boost his stake to 42% at Charlotte’s Web Holdings, signaling strong insider confidence in its cannabinoid growth potential.

Insider RSU sales at Cypherpunk Technologies hint at liquidity moves amid rising Ethereum buzz—why investors should watch the trend closely.

Insider Barchas Isaac sells 101k IMMUNOME shares at $21.12, raising liquidity amid a 21% weekly gain—watch for supply impact and future plans.

Shattuck Labs CTO’s disciplined 23k-share Rule 10(b)(5)(1) buys & sells reveal rule‑based equity management, not speculative bets.

Glenbrook Capital quietly ramps up SenesTech holdings, backing its pest‑control biotech as a bullish play amid a bearish market.

Inside Boundless Bio: Kevin Tang’s fresh 100k‑share buy signals optimism on ecDNA‑cancer therapy, partnership and leadership moves that could drive future upside.